March Sees New Surge of Nearly 200 Submitted ANDAs
The FDA received a fresh wave of ANDAs in March, nearly doubling the total amount from the first two months of the year.
Source: Drug Industry Daily
The FDA received a fresh wave of ANDAs in March, nearly doubling the total amount from the first two months of the year.
Source: Drug Industry Daily